Dimensional Fund Advisors
AURA icon

Dimensional Fund Advisors’s Aura Biosciences AURA Stock Holding History

Dimensional Fund Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.73M Buy
558,158
+40,242
+8% +$231K ﹤0.01% 2579
2025
Q4 		$2.82M Buy
517,916
+20,641
+4% +$123K ﹤0.01% 2662
2025
Q3 		$3.07M Buy
497,275
+41,118
+9% +$269K ﹤0.01% 2657
2025
Q2 		$2.86M Buy
456,157
+50,231
+12% +$294K ﹤0.01% 2666
2025
Q1 		$2.38M Buy
405,926
+40,102
+11% +$303K ﹤0.01% 2686
2024
Q4 		$3.01M Buy
365,824
+73,062
+25% +$688K ﹤0.01% 2682
2024
Q3 		$2.61M Buy
292,762
+42,387
+17% +$363K ﹤0.01% 2719
2024
Q2 		$1.89M Buy
250,375
+41,711
+20% +$306K ﹤0.01% 2770
2024
Q1 		$1.64M Buy
208,664
+30,946
+17% +$257K ﹤0.01% 2830
2023
Q4 		$1.58M Buy
177,718
+66,178
+59% +$560K ﹤0.01% 2837
2023
Q3 		$1M Buy
111,540
+71,520
+179% +$769K ﹤0.01% 2928
2023
Q2 		$494K Buy
+40,020
New +$428K ﹤0.01% 3064

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors's AURA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Aura Biosciences (AURA) stake by 7.8% in Q1 2026, buying an estimated $231K and bringing the position to 558,158 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2579.

Dimensional Fund Advisors first reported a position in AURA in Q2 2023 and has held it in 12 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Dimensional Fund Advisors held 558,158 shares of Aura Biosciences worth $3.73M as of Q1 2026.
  • Dimensional Fund Advisors bought 40,242 Aura Biosciences shares in Q1 2026, an estimated $231K.
  • Aura Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2579 holding.
  • Dimensional Fund Advisors first reported a position in Aura Biosciences in Q2 2023 and has held it in 12 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.